Gene sequencing machine maker Illumina forecast 2025 revenue largely below Wall Street estimates on Thursday, signaling ...

Genomics company Illumina (NASDAQ:ILMN) reported Q4 CY2024 results , but sales were flat year on year at $1.1 billion. On the ...

Discover the top genomics startups revolutionizing genome sequencing technologies to enhance disease prevention and treatment ...

The next-generation sequencing market valued at US$ 13.92 billion in 2023, is forecasted to grow at a robust CAGR of 11.0%, ...

NEW RESULTS FOR dual analysis of CTC-DNA and ctDNA using Illumina assay and sequencing platform. Findings in lung cancer show that CTCs can provide additional biomarkers not found ...

Bosses of big technology firms may find reassurance in comparing artificial intelligence to a lump of coal. Claimed ...

Rising demand for precision medicine & groundbreaking innovations in RNA sequencing drive growth in oncology, drug discovery, & personalized therapies. Akash Anand SNS Insider Pvt. Ltd 415-230-0044 ...

Illumina and Regeneron are taking stakes in ... Institutes of Health’s All of Us million-person program and other massive DNA sequencing projects. The companies—supported by more than a ...

Over the last 20 years, precision medicine has become the standard of care, but for many hospitals, the complexity of the ...

China retaliated against new U.S. tariffs soon after they took effect Tuesday, imposing duties on the imports of some American goods and launching an antitrust probe into Google, broadening the trade ...